CD28:B7-1[Biotinylated] Inhibitor Screening Assay Kit

Catalog #
72007
$1,070 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The CD28:B7-1[Biotinylated] Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of CD28:B7-1 signaling. The key to this kit is the high sensitivity of detection of biotin-labeled B7-1 by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, CD28 is coated on a 96-well plate. Next, B7-1 is incubated with CD28 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can be measured using a chemiluminescence reader.

Need us to run inhibitor screens or profile your compounds against CD28:B7-1[Biotinylated]? Check out our Immunotherapy Biochemical Screening Services.

Synonyms
CD80, B7.1, activity assay kit, Strep HRP, streptavidin
Product Info
Storage and Usage
Citations
Assay Kit Format
Chemiluminescent
Supplied As
This kit comes in a convenient 96-well format, with biotin-labeled B7-1, purified CD28, streptavidin-labeled HRP, and assay buffer for 100 binding reactions.
Materials Required But Not Supplied

PBS (Phosphate buffered saline)
Luminometer or microplate reader capable of reading chemiluminescence
Rotating or rocker platform

Format
Catalog # Component Amount Storage
71114 B7-1, Biotin-labeled 2 x 5 µg -80°C Avoid multiple
freeze/ thaw 
cycles
71113 CD28 10 µg -80°C
79742 Streptavidin-HRP 10 µl +4°C
79311 3x Immuno Buffer 1 50 ml -20°C
79728 Blocking Buffer 2 50 ml +4°C
  HRP chemiluminescent substrate A (transparent bottle) 6 ml +4°C
  HRP chemiluminescent substrate B (brown bottle) 6 ml +4°C
79699 White 96-well microplate 1 +4°C
UniProt #
P10747
Background
The activation of naïve T cells requires two signals, the specific T cell receptor recognition of MHC/Antigen on the surface of the antigen-presenting cell (APC), and the binding of B7-1 (CD80) ligand on the APC with the CD28 receptor on the T cell surface. CD28:B7-1 interaction is an important drug target for the regulation of T cells involved in autoimmunity, inflammation, tumor recognition, and immune tolerance.
References

1. Keir, M.E., et al. Immunol. Rev. 2005, 204: 128-143.
2. Haas, C., et al. Int. J. Cancer. 2006, 1;118: 658-667.